Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · IEX Real-Time Price · USD
-0.42 (-0.94%)
At close: Jun 18, 2024, 4:00 PM
-0.53 (-1.20%)
After-hours: Jun 18, 2024, 6:10 PM EDT

Crinetics Pharmaceuticals Revenue

Crinetics Pharmaceuticals had revenue of $1.97M in the twelve months ending March 31, 2024, down -53.93% year-over-year. Revenue in the quarter ending March 31, 2024 was $640.00K, a -76.11% decrease year-over-year. In the year 2023, Crinetics Pharmaceuticals had annual revenue of $4.01M, a decrease of -15.28%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.49B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20234.01M-724.00K-15.28%
Dec 31, 20224.74M3.66M339.42%
Dec 31, 20211.08M1.01M1,418.31%
Dec 31, 202071.00K-1.12M-94.05%
Dec 31, 20191.19M-1.24M-50.86%
Dec 31, 20182.43M383.00K18.73%
Dec 31, 20172.05M1.46M247.20%
Dec 31, 2016589.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.56B
Surgery Partners 2.79B
Prestige Consumer Healthcare 1.13B
Sotera Health Company 1.08B
Neogen 929.24M
Waystar Holding 747.13M
Ultragenyx Pharmaceutical 442.59M
Axonics 387.14M
Revenue Rankings